Hindustan Hardy Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 13, 2025, 12:00 am

Competitors of Hindustan Hardy Ltd

All Competitor Stocks of Hindustan Hardy Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:45 pm

Below is a detailed analysis of the quarterly data for Hindustan Hardy Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 26.75 Cr.. The value appears strong and on an upward trend. It has increased from 25.10 Cr. (Mar 2025) to 26.75 Cr., marking an increase of 1.65 Cr..
• For Expenses, as of Jun 2025, the value is 22.56 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21.34 Cr. (Mar 2025) to 22.56 Cr., marking an increase of 1.22 Cr..
• For Operating Profit, as of Jun 2025, the value is 4.19 Cr.. The value appears strong and on an upward trend. It has increased from 3.76 Cr. (Mar 2025) to 4.19 Cr., marking an increase of 0.43 Cr..
• For OPM %, as of Jun 2025, the value is 15.66%. The value appears strong and on an upward trend. It has increased from 14.98% (Mar 2025) to 15.66%, marking an increase of 0.68%.
• For Other Income, as of Jun 2025, the value is 0.31 Cr.. The value appears strong and on an upward trend. It has increased from 0.23 Cr. (Mar 2025) to 0.31 Cr., marking an increase of 0.08 Cr..
• For Interest, as of Jun 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.09 Cr..
• For Depreciation, as of Jun 2025, the value is 0.35 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.31 Cr. (Mar 2025) to 0.35 Cr., marking an increase of 0.04 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.06 Cr.. The value appears strong and on an upward trend. It has increased from 3.59 Cr. (Mar 2025) to 4.06 Cr., marking an increase of 0.47 Cr..
• For Tax %, as of Jun 2025, the value is 26.35%. The value appears to be improving (decreasing) as expected. It has decreased from 26.46% (Mar 2025) to 26.35%, marking a decrease of 0.11%.
• For Net Profit, as of Jun 2025, the value is 2.98 Cr.. The value appears strong and on an upward trend. It has increased from 2.64 Cr. (Mar 2025) to 2.98 Cr., marking an increase of 0.34 Cr..
• For EPS in Rs, as of Jun 2025, the value is 19.89. The value appears strong and on an upward trend. It has increased from 17.62 (Mar 2025) to 19.89, marking an increase of 2.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:08 am

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Hindustan Hardy Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 43.98. This value is within the healthy range. It has increased from 32.50 (Mar 24) to 43.98, marking an increase of 11.48.
• For Diluted EPS (Rs.), as of Mar 25, the value is 43.98. This value is within the healthy range. It has increased from 32.50 (Mar 24) to 43.98, marking an increase of 11.48.
• For Cash EPS (Rs.), as of Mar 25, the value is 51.48. This value is within the healthy range. It has increased from 39.01 (Mar 24) to 51.48, marking an increase of 12.47.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 197.00. It has increased from 155.45 (Mar 24) to 197.00, marking an increase of 41.55.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 197.00. It has increased from 155.45 (Mar 24) to 197.00, marking an increase of 41.55.
• For Dividend / Share (Rs.), as of Mar 25, the value is 2.80. This value is within the healthy range. It has increased from 2.50 (Mar 24) to 2.80, marking an increase of 0.30.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 543.56. It has increased from 452.71 (Mar 24) to 543.56, marking an increase of 90.85.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 68.40. This value is within the healthy range. It has increased from 52.17 (Mar 24) to 68.40, marking an increase of 16.23.
• For PBIT / Share (Rs.), as of Mar 25, the value is 60.90. This value is within the healthy range. It has increased from 45.65 (Mar 24) to 60.90, marking an increase of 15.25.
• For PBT / Share (Rs.), as of Mar 25, the value is 59.71. This value is within the healthy range. It has increased from 44.03 (Mar 24) to 59.71, marking an increase of 15.68.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 43.98. This value is within the healthy range. It has increased from 32.49 (Mar 24) to 43.98, marking an increase of 11.49.
• For PBDIT Margin (%), as of Mar 25, the value is 12.58. This value is within the healthy range. It has increased from 11.52 (Mar 24) to 12.58, marking an increase of 1.06.
• For PBIT Margin (%), as of Mar 25, the value is 11.20. This value is within the healthy range. It has increased from 10.08 (Mar 24) to 11.20, marking an increase of 1.12.
• For PBT Margin (%), as of Mar 25, the value is 10.98. This value is within the healthy range. It has increased from 9.72 (Mar 24) to 10.98, marking an increase of 1.26.
• For Net Profit Margin (%), as of Mar 25, the value is 8.09. This value is within the healthy range. It has increased from 7.17 (Mar 24) to 8.09, marking an increase of 0.92.
• For Return on Networth / Equity (%), as of Mar 25, the value is 22.32. This value is within the healthy range. It has increased from 20.90 (Mar 24) to 22.32, marking an increase of 1.42.
• For Return on Capital Employeed (%), as of Mar 25, the value is 27.90. This value is within the healthy range. It has increased from 26.70 (Mar 24) to 27.90, marking an increase of 1.20.
• For Return On Assets (%), as of Mar 25, the value is 11.60. This value is within the healthy range. It has increased from 11.32 (Mar 24) to 11.60, marking an increase of 0.28.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 0.2. It has increased from 0.08 (Mar 24) to 0.09, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.25, marking an increase of 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.63. It has decreased from 1.71 (Mar 24) to 1.63, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.71, marking a decrease of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 1.31. This value is within the healthy range. It has decreased from 1.43 (Mar 24) to 1.31, marking a decrease of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.88. This value exceeds the healthy maximum of 8. It has increased from 5.68 (Mar 24) to 9.88, marking an increase of 4.20.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 5.68. This value is below the healthy minimum of 20. It has decreased from 6.77 (Mar 24) to 5.68, marking a decrease of 1.09.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 20. It has decreased from 5.63 (Mar 24) to 4.85, marking a decrease of 0.78.
• For Earning Retention Ratio (%), as of Mar 25, the value is 94.32. This value exceeds the healthy maximum of 70. It has increased from 93.23 (Mar 24) to 94.32, marking an increase of 1.09.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.15. This value exceeds the healthy maximum of 70. It has increased from 94.37 (Mar 24) to 95.15, marking an increase of 0.78.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 57.39. This value is within the healthy range. It has increased from 32.27 (Mar 24) to 57.39, marking an increase of 25.12.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 37.90. This value is within the healthy range. It has increased from 21.10 (Mar 24) to 37.90, marking an increase of 16.80.
• For Enterprise Value (Cr.), as of Mar 25, the value is 105.26. It has increased from 60.86 (Mar 24) to 105.26, marking an increase of 44.40.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.29. This value is within the healthy range. It has increased from 0.89 (Mar 24) to 1.29, marking an increase of 0.40.
• For EV / EBITDA (X), as of Mar 25, the value is 10.27. This value is within the healthy range. It has increased from 7.79 (Mar 24) to 10.27, marking an increase of 2.48.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 0.89 (Mar 24) to 1.24, marking an increase of 0.35.
• For Retention Ratios (%), as of Mar 25, the value is 94.31. This value exceeds the healthy maximum of 70. It has increased from 93.22 (Mar 24) to 94.31, marking an increase of 1.09.
• For Price / BV (X), as of Mar 25, the value is 3.43. This value exceeds the healthy maximum of 3. It has increased from 2.62 (Mar 24) to 3.43, marking an increase of 0.81.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 0.89 (Mar 24) to 1.24, marking an increase of 0.35.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness